Huang Y - Search Results

1

A novel androgen-reduced prostate-specific lncRNA, PSLNR, inhibits prostate-cancer progression in part by regulating the p53-dependent pathway.

Wang D, Wan X, Zhang Y, Kong Z, Lu Y, Sun X, Huang Y, Ji C, Li D, Luo J, Gu W, Wang C, Li Y, Xu Y. Wang D, et al. Among authors: huang y. Prostate. 2019 Sep;79(12):1362-1377. doi: 10.1002/pros.23840. Epub 2019 Jul 3. Prostate. 2019. PMID: 31269242

2

KDM1A triggers androgen-induced miRNA transcription via H3K4me2 demethylation and DNA oxidation.

Yang S, Zhang J, Zhang Y, Wan X, Zhang C, Huang X, Huang W, Pu H, Pei C, Wu H, Huang Y, Huang S, Li Y. Yang S, et al. Among authors: huang s, huang x, huang w, huang y. Prostate. 2015 Jun 15;75(9):936-46. doi: 10.1002/pros.22977. Epub 2015 Mar 1. Prostate. 2015. PMID: 25728837

3

Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancer.

Wan X, Huang W, Yang S, Zhang Y, Pu H, Fu F, Huang Y, Wu H, Li T, Li Y. Wan X, et al. Among authors: huang w, huang y. Oncotarget. 2016 Sep 13;7(37):60503-60518. doi: 10.18632/oncotarget.11391. Oncotarget. 2016. PMID: 27556357 Free PMC article.

4

Overexpression of AR-regulated lncRNA TMPO-AS1 correlates with tumor progression and poor prognosis in prostate cancer.

Huang W, Su X, Yan W, Kong Z, Wang D, Huang Y, Zhai Q, Zhang X, Wu H, Li Y, Li T, Wan X. Huang W, et al. Among authors: huang y. Prostate. 2018 Dec;78(16):1248-1261. doi: 10.1002/pros.23700. Epub 2018 Aug 13. Prostate. 2018. PMID: 30105831

5

Androgen-responsive lncRNA LINC00304 promotes cell cycle and proliferation via regulating CCNA1.

Zhang P, Lu Y, Kong Z, Zhang Y, Fu F, Su X, Huang Y, Wan X, Li Y. Zhang P, et al. Among authors: huang y. Prostate. 2019 Jun;79(9):994-1006. doi: 10.1002/pros.23811. Epub 2019 Apr 23. Prostate. 2019. PMID: 31012142

6

Comprehensive Characterization of Androgen-Responsive lncRNAs Mediated Regulatory Network in Hormone-Related Cancers.

Wang D, Li M, Li J, Wan X, Huang Y, Wang C, Zhang P, Xu Y, Kong Z, Lu Y, Wang X, Liu C, Ji C, Li L. Wang D, et al. Among authors: huang y. Dis Markers. 2020 Sep 26;2020:8884450. doi: 10.1155/2020/8884450. eCollection 2020. Dis Markers. 2020. PMID: 33082888 Free PMC article.

7

Comprehensive Characterization of Androgen-Responsive circRNAs in Prostate Cancer.

Kong Z, Lu Y, Wan X, Luo J, Li D, Huang Y, Wang C, Li Y, Xu Y. Kong Z, et al. Among authors: huang y. Life (Basel). 2021 Oct 15;11(10):1096. doi: 10.3390/life11101096. Life (Basel). 2021. PMID: 34685466 Free PMC article.

8

Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.

Jiang M, Li M, Fu X, Huang Y, Qian H, Sun R, Mao Y, Xie Y, Li Y. Jiang M, et al. Among authors: huang y. Prostate. 2008 Oct 1;68(14):1496-509. doi: 10.1002/pros.20756. Prostate. 2008. PMID: 18366025

9

Identification of novel AR-targeted microRNAs mediating androgen signalling through critical pathways to regulate cell viability in prostate cancer.

Mo W, Zhang J, Li X, Meng D, Gao Y, Yang S, Wan X, Zhou C, Guo F, Huang Y, Amente S, Avvedimento EV, Xie Y, Li Y. Mo W, et al. Among authors: huang y. PLoS One. 2013;8(2):e56592. doi: 10.1371/journal.pone.0056592. Epub 2013 Feb 22. PLoS One. 2013. PMID: 23451058 Free PMC article.

10

Identification of miR-133b and RB1CC1 as independent predictors for biochemical recurrence and potential therapeutic targets for prostate cancer.

Li X, Wan X, Chen H, Yang S, Liu Y, Mo W, Meng D, Du W, Huang Y, Wu H, Wang J, Li T, Li Y. Li X, et al. Among authors: huang y. Clin Cancer Res. 2014 May 1;20(9):2312-25. doi: 10.1158/1078-0432.CCR-13-1588. Epub 2014 Mar 7. Clin Cancer Res. 2014. PMID: 24610824

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81,746 results

Search Page

Filters